|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02496 YZYBIO-B
Nominal 
5.950 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 | 0 |
| Cost of Sales | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | (24,629) | 109.163% | (11,775) | (2,670) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | (191,702) | 1.502% | (188,866) | (148,518) | |
| Taxation | 0 | -- | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (191,702) | 1.502% | (188,866) | (148,518) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,341 | -38.627% | 2,185 | 14,810 |
| Depreciation & Amortisation | 7,316 | 5.357% | 6,944 | 7,617 |
| Directors' Emoluments | 2,821 | 22.227% | 2,308 | 12,835 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | |
| EPS (cts) | -104.000 | -5.455% | -110.000 | -- |
| DPS (cts) | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | (1.005) | -- | (1.027) | -- |
| NBV per share ($) | 0.659 | -- | -- | -- |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -78,396,000 |
| %Change | -9.440% |
| EPS / (LPS) | RMB -0.400 |
| NBV Per Share (¥) | RMB 0.256 |